New data from the Novartis chronic obstructive pulmonarydisease (COPD) portfolio were presented today at the American Thoracic Society(ATS) International Conference May 17-22, 2013 in Philadelphia, PA, USA.

NEW YORK (TheStreet) - Watson Pharmaceuticals, founded by a Taiwanese immigrant in the early 1980s and now a rival to generic drug giants Teva Pharmaceuticalsand Novartis , is such an American success story the company has wound up in Ireland.On Mond

Atlas Venture collected $265 million for its most recent fund, a source tells peHUB. The VC announced Thursday thatAmgen Ventures and Novartis are new LPs of fund IX. The post Atlas Venture Closes Fund IX with $265 Million appeared first on peHUB.

* Novartis' one-third stake in Roche built up under Vasella

* Novartis' one-third stake in Roche built up under Vasella

* Novartis' one-third stake in Roche built up under Vasella

ZURICH, May 16 (Reuters) - Novartis has no plans to bid for U.S.-based generic drugmaker Actavis, which is the subject of intense takeover speculation, a spokesman for the Swiss drugmaker said on...

ZURICH, May 16 (Reuters) - Novartis has no plans to bid for U.S.-based generic drugmaker Actavis, which is the subject of intense takeover speculation, a spokesman for the Swiss drugmaker said on Thursday.

A heated takeover battle has erupted around generic-drug company Actavis. Swiss pharmaceuticals giant Novartis is considering whether to enter the fray, while Valeant and Mylan are evaluating their options after approaches they made for Actavis were

LONDON, May 10 (Reuters) - European shares scaled fresh five-year highs on Friday, led by healthcare group Novartis and telecoms firm BT on positive corporate news, and traders said key indexes had scope for more gains.

LONDON, May 10 (Reuters) - European shares scaled fresh five-year highs on Friday, led by healthcare group Novartis and telecoms firm BT on positive corporate news, and traders said key indexes had...

ZURICH, May 10 (Reuters) - Novartis said on Friday the U.S. Food and Drug Administration (FDA) had approved its drug Ilaris to treat a serious form of childhood arthritis.

Incyte Corporation (NASDAQ: INCY) announced today that it has earned a $25.0million milestone payment from Novartis based on the formal initiation of aPhase II clinical trial evaluating c-MET inhibitor INC280 (formerly INCB28060)as monotherapy in pat

Doctors were treated to outrageously expensive dinners at Manhattan's Nobu as well as kickbacks when patients switched over to Novartis drugs.

NEW YORK (Reuters) - The U.S. government on Friday announced its second civil fraud lawsuit against Novartis AG in four days, accusing a unit of the Swiss drugmaker of paying multimillion-dollar kickbacks to doctors in exchange for prescribing its dr

The government joined a whistle-blower lawsuit that said a unit of Novartis paid millions to doctors in exchange for prescribing its drugs.    

NEW YORK, April 26 (Reuters) - The U.S. government on Friday announced its second civil fraud lawsuit against Novartis AG in four days, accusing a unit of the Swiss drugmaker of paying multimillion-dollar kickbacks to doctors in exchange for prescrib

NEW YORK, April 26 (Reuters) - The U.S. government on Friday announced its second civil fraud lawsuit against Novartis AG in four days, accusing a unit of the Swiss drugmaker of paying multimillion-dollar kickbacks to doctors in exchange for prescrib

NEW YORK, April 26 (Reuters) - The U.S. government on Fridayannounced its second civil fraud lawsuit against Novartis AG in four days, accusing a unit of the Swiss drugmakerof paying...

NEW YORK (MarketWatch) -- Novartis Pharmaceuticals, the U.S. unit of Novartis AG , allegedly paid kickbacks to health-care providers to encourage them to prescribe their drugs, according to a complaint filed by the Justice Department on Friday. This

Federal prosecutors accused the U.S. unit of Novartis of paying kickbacks and providing lavish dinners to doctors to encourage them to prescribe their brand-name drugs to treat hypertension and other maladies.

In its second civil fraud lawsuit against Novartis in four days, the government joined a whistleblower suit accusing a unit of the Swiss drugmaker of paying kickbacks to doctors.    

(Reuters) - The government on Friday announced its second civil fraud lawsuit against Novartis AG in four days, accusing a unit of the Swiss drugmaker of paying multi-million dollar kickbacks to doctors in exchange for prescribing its drugs.

The government on Friday announced its second civil fraud lawsuit against Novartis AGin four days, accusing a unit of the Swiss drugmaker of paying multi-million dollar kickbacks to doctors in exchange for prescribing its drugs.

April 26 (Reuters) - The U.S. government on Friday announcedits second civil fraud lawsuit against Novartis AG infour days, accusing a unit of the Swiss drugmaker of payingmulti-million dollar...

April 26 (Reuters) - The U.S. government on Friday announced its second civil fraud lawsuit against Novartis AG in four days, accusing a unit of the Swiss drugmaker of paying multi-million dollar kickbacks to doctors in exchange for prescribing its d

April 26 (Reuters) - Novartis AG : * U.S. says joins whistleblower lawsuit against Novartis AG over

Best-performing investments for world’s biggest SWF were BlackRock, Nestlé and Novartis while the worst were Apple, Santander and BHP Billiton

Call Start:08:00Call End:09:14Novartis AG (NVS)Q12013 Earnings CallApril 24, 2013 8:00 am ETExecutivesJoseph Jimenez - Chief Executive Officer, Member of the Executive CommitteeSamir Shah - Global Head, Investor RelationsJonathan Symonds - Chief Fina

Here's your Cheat Sheet to earnings...

Swiss pharmaceuticals group promotes Harry Kirsch to role of chief financial officer in the second high-profile reshuffle of the past three months

The Swiss drug maker posted a rise in first-quarter net profit, as new product launches and strength in emerging markets helped offset declining sales of blockbuster heart drug Diovan.

MADRID (MarketWatch) -- Federal prosecutors late Tuesday accused Novartis Pharmaceuticals Corp. of bribing pharmacies to switch kidney patients from generic drugs to the company's own product, boosting its drug sales in the process. The civil lawsuit

* Reports earnings per share of $1.32 vs estimates for $1.30

* Reports earnings per share of $1.32 vs estimates for $1.30

ZURICH, April 24 (Reuters) - Novartis AG : * Says will cut some 300 positions at consumer health unit, as downsizes

ZURICH, April 24 (Reuters) - Swiss drugmaker Novartis named Harry Kirsch as new Chief Financial Officer to help improve productivity as the Basel-based drugmaker looks to grow beyond a wave of patent expiries.

ZURICH, April 24 (Reuters) - Swiss drugmaker Novartis named Harry Kirsch as new Chief Financial Officer to help improve productivity as the Basel-based drugmaker looks to grow beyond a wave of patent expiries.

Federal prosecutors accused the U.S. unit of Swiss drug giant Novartis of paying kickbacks to get pharmacies to switch kidney-transplant patients from generic drugs to the company's brand-name anti-rejection drug, Myfortic.

A lawsuit accuses the drug company of giving pharmacies discounts in exchange for promoting a drug.    

(Reuters) - The U.S. government filed a civil fraud lawsuit against Novartis AG on Tuesday, accusing a unit of the Swiss drug maker of causing the Medicare and Medicaid programs to pay tens of millions of dollars in reimbursements based on fraudulent

* Civil fraud lawsuit alleges improper payments * U.S. says Novartis sought to boost sales of Myfortic * Novartis had no immediate comment By Bernard...

(Reuters) - The U.S. government filed a civil fraud lawsuit against Novartis AG on Tuesday, accusing a unit of the Swiss drug maker of causing the Medicare and Medicaid programs to pay tens of millions of dollars in reimbursements based on fraudulent

April 23 (Reuters) - The U.S. government filed a civil fraud lawsuit against Novartis AG on Tuesday, accusing a unit of the Swiss drug maker of causing the Medicare and Medicaid programs to pay tens of millions of dollars in reimbursements based on f

April 23 (Reuters) - The U.S. government filed a civil fraudlawsuit against Novartis AG on Tuesday, accusing aunit of the Swiss drug maker of causing the Medicare andMedicaid programs to pay tens...

April 23 (Reuters) - The U.S. government filed a civil fraud lawsuit against Novartis AG on Tuesday, accusing a unit of the Swiss drug maker of causing the Medicare and Medicaid programs to pay tens of millions of dollars in reimbursements based on f

Novartis AGwas sued on Tuesday by the United States, which accused the Swiss drug maker of using kickbacks to induce pharmacies to steer thousands of patients to its drug Myfortic, which is used for people who have undergone kidney transplants.

The lawsuit accuses the Swiss drug maker of using kickbacks to induce pharmacies to steer thousands of patients to its drug Myfortic, which is used for people who have undergone kidney transplants.